Events and webinars

Tokyo: Life Sciences and Health Care Horizons 2023

Key Life Sciences issues for Japanese companies

Zurich: Life Sciences and Health Care Horizons 2023

Staying ahead of the game: Pharma trends

Marketing with Health Data: A discussion of the current state and uncertainty of how and when health and life sciences companies may use health or other sensitive data in connection with marketing, advertising and other promotional activities in the U.S.

Use of health and sensitive data in connection with US marketing activities has grown complex. Most recently, focus has been on the use of tracking technologies. FTC enforcement actions in...

AI Health Law & Policy Summit

Hogan Lovells hosted our annual AI Health Law & Policy Summit on Thursday, 18 May 2023. This was an informative and interactive program where our thought leaders and industry guests...

Digital health: The key things insurers need to know

The session will focus on the key things that traditional insurance companies need to know about operating in the digital health space. A growing number of traditional insurance companies...

Privacy and cybersecurity breakfast seminars on U.S. and life sciences developments in Amsterdam

The privacy and cybersecurity landscape will be undergoing significant changes in 2023. We are expecting substantial U.S. legislative and regulatory updates throughout the year, as well as...

Unpacking the prescription drug provisions of the Inflation Reduction Act of 2022

On 7 August, 2022, the Senate passed the proposed Inflation Reduction Act of 2022, which includes a number of significant prescription drug-related provisions. The bill generally revives...

Health Care AI Law and Policy Summit

Creation and adoption of artificial intelligence (AI) systems promise better health care management for patients and faster, more accurate diagnoses for doctors. Companies pursuing AI...

Loading data